About Cytarabine Injection BP Cyterawin 1000
Discover Cyterawin 1000, the best-seller in oncology care. This popular and first-string Cytarabine Injection BP offers a hot deal for medical facilities and distributors in India. Formulated as a wondrous, sterile, ready-to-use solution, Cyterawin 1000 comes in a glass vial containing 1000 mg Cytarabine, suitable for intravenous or subcutaneous administration. Perfect for treatment protocols targeting acute and chronic leukemia, this injection adheres to British Pharmacopoeia standards. Packaged for safety and stability, it is preserved and compatible with standard infusion fluids. Only available on prescription and handled under strict cytotoxic safety precautions.
Key Uses and Features of Cyterawin 1000
Cytarabine Injection BP Cyterawin 1000 is primarily used in chemotherapy for acute myeloid leukemia, acute lymphocytic leukemia, and chronic myelogenous leukemia in blast crisis. Its sterile glass vial ensures untainted delivery of this crucial chemotherapy agent. Ready-to-use, the formulation simplifies medical workflow. Its competitive advantages include compliance with BP standards, versatile compatibility with infusion fluids, and reliable stability, making it a preferred choice in oncology departments and among healthcare professionals nationwide.
Delivery, Certifications, and Shipping Details
Domestic markets rely on Cyterawin 1000 for rapid and consistent supply. We offer express shipping options and seamless execution from FOB ports in India to ensure timely delivery. All shipments are certified to meet exacting standards, and exchange policies are available subject to applicable terms. Whether you are a dealer, distributor, or direct buyer, our logistics prioritize product safety and prompt arrival to clinical settings.
FAQ's of Cytarabine Injection BP Cyterawin 1000:
Q: How is Cyterawin 1000 administered to patients?
A: Cyterawin 1000 is administered through intravenous or subcutaneous injection, as directed by a medical professional, and dosage must be adjusted according to the specific treatment protocol.
Q: What specific types of leukemia is Cyterawin 1000 indicated for?
A: This injection is predominantly used for acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML) in blast crisis, as prescribed by oncologists.
Q: Where should Cyterawin 1000 be stored for optimal effectiveness?
A: The vials should be stored at 2C to 8C, protected from light, and must not be frozen to maintain product integrity and efficacy.
Q: When does Cyterawin 1000 expire?
A: The typical shelf life for Cyterawin 1000 is between 24 and 36 months from the date of manufacture, always check the manufacturer's label for the exact expiration.
Q: What safety precautions are necessary during the handling of Cyterawin 1000?
A: Due to its cytotoxic nature, the injection must be handled with appropriate personal protective equipment to minimize the risk of exposure during preparation and administration.
Q: How does Cyterawin 1000 offer competitive advantages for health facilities?
A: Cyterawin 1000 meets BP quality standards, offers flexible administration options, and is available as both single-dose and multi-dose vials, making it ideal for a variety of chemotherapy regimens.